Showing results (361-370 of 414) with videos related to

Sort By:
Pageof 42
The New England Journal of Medicine|March 10, 2006
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis BTing-Tsung Chang, Robert G Gish, Robert de Man, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 22, 2020
Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional studyHarrys A Torres, Anna S Lok, Maria E Suarez-Almazor, et al.
Alimentary Pharmacology & Therapeutics|October 30, 2015
Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE studyJ Ahn, H M Lee, J K Lim, et al.
Contemporary Clinical Trials|March 27, 2017
Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatmentDonna M Evon, Carol E Golin, Paul Stewart, et al.
Gastroenterology|September 15, 2009
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trialMitchell L Shiffman, Chihiro Morishima, Jules L Dienstag, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 24, 2021
Weight Loss and Weight Regain in Usual Clinical Practice: Results From the TARGET-NASH Observational CohortMiguel H Malespin, Alfred Sidney Barritt, Stephanie E Watkins, et al.
Controlled Clinical Trials|October 7, 2004
Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonrespondersWilliam M Lee, Jules L Dienstag, Karen L Lindsay, et al.
Journal of Internal Medicine|November 20, 2023
Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survivalSimon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.
Hepatology Communications|June 18, 2021
Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET-NASH StudyA Sidney Barritt, Stephanie Watkins, Norman Gitlin, et al.
Gastroenterology|April 14, 2009
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinomaJorge A Marrero, Ziding Feng, Yinghui Wang, et al.
Pageof 42